1016PSurrogate endpoint of progression-free (PFS) and...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1016PSurrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study

Lecuru, F, Pujade-Lauraine, E, Hamizi, S, Caumont-Prim, A, Raban, N, Malaurie, E, Pautier, P, Kaminsky-Forrett, M-C, Meunier, J, Alexandre, J, Berton-Rigaud, D, Dohollou, N, Dubot, C, Floquet, A, Favi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.024
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed